{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:24:57Z","timestamp":1789136697120,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003107","name":"German Federal Ministry of Health","doi-asserted-by":"publisher","award":["ZMVI1-2519DSM200"],"award-info":[{"award-number":["ZMVI1-2519DSM200"]}],"id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.comppsych.2025.152607","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T14:15:36Z","timestamp":1747577736000},"page":"152607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Screening accuracy of the German version of the benzodiazepine self-report questionnaire"],"prefix":"10.1016","volume":"141","author":[{"given":"M.W.","family":"Stratmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Heeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"H\u00e4rter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kriston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Verthein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2025.152607_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"PS"},{"key":"10.1016\/j.comppsych.2025.152607_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.comppsych.2025.152607_bb0015","author":"National Institute for Clinical Excellence [NICE]"},{"key":"10.1016\/j.comppsych.2025.152607_bb0020","first-page":"2","volume":"21","author":"Riemann","year":"2017","journal-title":"S3-Leitlinie Nicht erholsamer Schlaf\/Schlafst\u00f6rungen"},{"key":"10.1016\/j.comppsych.2025.152607_bb0025","series-title":"Diagnostisches und Statistisches Manual Psychischer St\u00f6rungen DSM-5\u00ae","author":"American Psychiatric Association","year":"2018"},{"key":"10.1016\/j.comppsych.2025.152607_bb0030","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.eurpsy.2015.09.003","article-title":"Long-term use of benzodiazepines: definitions, prevalence and usage patterns\u2013a systematic review of register-based studies","volume":"30","author":"Kurko","year":"2015","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152607_bb0035","first-page":"E52","article-title":"Long-term sedative use among community-dwelling adults: a population-based analysis","volume":"5","author":"Weymann","year":"2017","journal-title":"Can Med Assoc Open Access J"},{"key":"10.1016\/j.comppsych.2025.152607_bb0040","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.896","article-title":"Long-term benzodiazepines and z-drug prescribing in Australian general practice between 2011 and 2018: a national study","volume":"10","author":"Woods","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.comppsych.2025.152607_bb0045","first-page":"607","article-title":"Problematic medication with benzodiazepines,\u201cZ-drugs\u201d, and opioid analgesics: an analysis of National Health Insurance prescription data from 2006\u20132016","volume":"116","author":"Buth","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.comppsych.2025.152607_bb0050","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00115-014-4016-8","article-title":"Benzodiazepinhypnotika, Zolpidem und Zopiclon auf Privatrezept: Verbrauch zwischen 1993 und 2012","volume":"85","author":"Hoffmann","year":"2014","journal-title":"Nervenarzt"},{"key":"10.1016\/j.comppsych.2025.152607_bb0055","article-title":"The role of private prescriptions in benzodiazepine and Z-drug use\u2014a secondary analysis of office-based prescription data","author":"Grimmsmann","year":"2022","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.comppsych.2025.152607_bb0060","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1055\/a-2160-2679","article-title":"Privatverordnungen von Benzodiazepinen und Z-Substanzen in Ost- und Westdeutschland \u2013 eine Sekund\u00e4rdatenanalyse","volume":"85","author":"Grimmsmann","year":"2023","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.comppsych.2025.152607_bb0065","first-page":"527","article-title":"The use of psychoactive substances in Germany","volume":"119","author":"Rauschert","year":"2022","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.comppsych.2025.152607_bb0070","series-title":"Non-Medical Use of Medicines: Health and Social Responses","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2021"},{"key":"10.1016\/j.comppsych.2025.152607_bb0075","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"key":"10.1016\/j.comppsych.2025.152607_bb0080","first-page":"123","article-title":"Entwicklung eines Fragebogens zur Erfassung von Medikamentenmi\u00dfbrauch bei Suchtpatienten","volume":"3","author":"Watzl","year":"1991","journal-title":"Sucht Und Psychosomatik Beitr\u00e4ge Des"},{"key":"10.1016\/j.comppsych.2025.152607_bb0085","series-title":"Deutsche Gesellschaft f\u00fcr Suchtforschung und Suchttherapie (DG-Sucht). S3-Leitlinie Medikamentenbezogene St\u00f6rungen","author":"Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde (DGPPN)","year":"2020"},{"key":"10.1016\/j.comppsych.2025.152607_bb0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1360-0443.2000.95224511.x","article-title":"The severity of dependence scale (SDS) as screening test for benzodiazepine dependence: SDS validation study","volume":"95","author":"Cuevas","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.comppsych.2025.152607_bb0095","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12877-019-1182-3","article-title":"The severity of dependence scale detects medication misuse and dependence among hospitalized older patients","volume":"19","author":"Cheng","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.comppsych.2025.152607_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.kjms.2011.06.023","article-title":"The Chinese version of the severity of dependence scale as a screening tool for benzodiazepine dependence in Taiwan","volume":"28","author":"Tsai","year":"2012","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.comppsych.2025.152607_bb0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/a-1128-5050","article-title":"Effektivit\u00e4t von Screeningverfahren zur Identifizierung von Medikamentenabh\u00e4ngigkeit: Vergleich der Severity of Dependence Scale (SDS) und des Kurzfragebogens zu Medikamentenmissbrauch (KMM)","volume":"21","author":"Bischof","year":"2020","journal-title":"Suchttherapie"},{"key":"10.1016\/j.comppsych.2025.152607_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0010-440X(99)90129-3","article-title":"Scalability, reliability, and validity of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users","volume":"40","author":"Kan","year":"1999","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152607_bb0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1590\/2237-6089-2019-0049","article-title":"Psychometric properties of the benzodiazepine dependence self-report questionnaire \u2013 Portuguese version (BENDEP-SRQ-PV)","volume":"42","author":"Curado","year":"2020","journal-title":"Trends Psychiatry Psychother"},{"key":"10.1016\/j.comppsych.2025.152607_bb0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12888-021-03196-0","article-title":"Prevalence of and factors associated with acute withdrawal symptoms after 24 weeks of eszopiclone treatment in patients with chronic insomnia: a prospective, interventional study","volume":"21","author":"Inoue","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152607_bb0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/comp.2001.26275","article-title":"Cross-validation of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users","volume":"42","author":"Kan","year":"2001","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152607_bb0130","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/comp.2001.26276","article-title":"Latent trait standardization of the benzodiazepine dependence self-report questionnaire using the Rasch scaling model","volume":"42","author":"Kan","year":"2001","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152607_bb0135","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1081\/JA-100104491","article-title":"Assessment of benzodiazepine dependence in alcohol and drug dependent outpatients: a research report","volume":"36","author":"Kan","year":"2001","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.comppsych.2025.152607_bb0140","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0010-440X(03)00040-3","article-title":"Cross-validation, predictive validity, and time course of the benzodiazepine dependence self-report questionnaire in a benzodiazepine discontinuation trial","volume":"44","author":"Oude Voshaar","year":"2003","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.comppsych.2025.152607_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s11469-024-01396-9","article-title":"Psychometric properties of the German version of the benzodiazepine dependence self-report questionnaire","author":"Heeg","year":"2024","journal-title":"Int J Ment Health Addict"},{"key":"10.1016\/j.comppsych.2025.152607_bb0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/a-1502-0961","article-title":"Akzeptanz und Nutzung einer Website mit Gesundheitsinformationen zu psychischen Erkrankungen \u2013 www.psychenet.de","volume":"49","author":"K\u00f6hnen","year":"2022","journal-title":"Psychiatr Prax"},{"key":"10.1016\/j.comppsych.2025.152607_bb0155","series-title":"LimeSurvey: An Open Source Survey Tool","author":"LimeSurvey Project Team \/ Carsten Schmitz","year":"2012"},{"key":"10.1016\/j.comppsych.2025.152607_bb0160","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s11136-021-02822-4","article-title":"COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures","volume":"30","author":"Gagnier","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/j.comppsych.2025.152607_bb0165","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.comppsych.2025.152607_bb0170","year":"2019"},{"key":"10.1016\/j.comppsych.2025.152607_bb0175","series-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2021"},{"key":"10.1016\/j.comppsych.2025.152607_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinform"},{"key":"10.1016\/j.comppsych.2025.152607_bb0185","doi-asserted-by":"crossref","first-page":"879","DOI":"10.7326\/0003-4819-149-12-200812160-00007","article-title":"Meta-analysis: are 3 questions enough to detect unhealthy alcohol use?","volume":"149","author":"Kriston","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.comppsych.2025.152607_bb0190","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/jama.2020.22106","article-title":"Balancing the risks and benefits of benzodiazepines","volume":"325","author":"Hirschtritt","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.comppsych.2025.152607_bb0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13722-018-0110-8","article-title":"Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff","volume":"13","author":"McNeely","year":"2018","journal-title":"Addict Sci Clin Pract"},{"key":"10.1016\/j.comppsych.2025.152607_bb0200","series-title":"Statt low-dose oder Sucht \u2013 Das 5-Phasen-Modell des Benzodiazepin-Langzeitgebrauchs. Sucht","volume":"134","author":"Holzbach","year":"2014"},{"key":"10.1016\/j.comppsych.2025.152607_bb0205","series-title":"Medikamentenabh\u00e4ngigkeit","volume":"vol. 5","author":"Glaeske","year":"2020"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X25000355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X25000355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:12:55Z","timestamp":1749859975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X25000355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":41,"alternative-id":["S0010440X25000355"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2025.152607","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening accuracy of the German version of the benzodiazepine self-report questionnaire","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2025.152607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152607"}}